Breast Cancer. Malignant neoplasm of central portion of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Metastatic breast cancer patients undergoing hormone therapy in the last year Absence of fatty liver Inactivity in the last 6 months Not having a medical prohibition to participate in sports activities Absence of fracture and the possibility of its occurrence Not having an abnormality limiting sports activity Absence of cardiovascular and skeletal-muscular risk factors Absence of uncontrolled pain More than a month has passed since chemotherapy and radiotherapy
Exclusion criteria
Exclusion criteria: The presence of a fracture Alcohol and smoking Age less than 30 and more than 50 Patients who are in the treatment phase of chemotherapy or radiation therapy Male patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor markers CEA? CA15-3. Timepoint: 24 hours before the intervention and 24 hours after the last training session. Method of measurement: Taking blood samples.;Liver enzymes ALT, AST and ALP. Timepoint: 24 hours before the intervention and 24 hours after the last training session. Method of measurement: Taking blood samples.;Quality of life. Timepoint: 24 hours before the intervention and 24 hours after the last training session. Method of measurement: Questionnaire.;Fatigue. Timepoint: 24 hours before the intervention and 24 hours after the last training session. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Razi University